The DOI matches its Crossref record; 359 of the 359 references it cites were found in a registry or an index.
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–359 of 359
Mora, S., Buring, J. E., & Ridker, P. M. (2014) · Circulation · doi:10.1161/circulationaha.113.005873 · Cited by 255
Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251
Wei, M. Y., Ito, M. K., Cohen, J. D., Brinton, E. A., & Jacobson, T. A. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.03.001 · Cited by 250
Self-citationPearson, T. A., Denke, M. A., McBride, P. E., Battisti, W. P., Brady, W. E., & Palmisano, J. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.5.587 · Cited by 247
Combination lipid therapy in type 2 diabetes
(2010) · New England Journal of Medicine · doi:10.1056/nejmc1006407 · Cited by 245
Lee, M., Saver, J. L., Towfighi, A., Chow, J., & Ovbiagele, B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.020 · Cited by 240
High-Density Lipoprotein and Coronary Heart Disease
Natarajan, P., Ray, K. K., & Cannon, C. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.008 · Cited by 230
Sniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00262-5 · Cited by 224
Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0408 · Cited by 216
Lowering LDL—not only how low, but how long?
Brown, M. S., & Goldstein, J. L. (2006) · Science · doi:10.1126/science.1125884 · Cited by 204
Secondary causes of hyperlipidemia.
Stone, N. J. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30179-1 · Cited by 199
Frost, P. H., & Havel, R. J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00034-4 · Cited by 193
The importance of non–HDL cholesterol reporting in lipid management
Blaha, M. J., Blumenthal, R. S., Brinton, E. A., & Jacobson, T. A. (2008) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2008.06.013 · Cited by 193
Self-citationHou, W., Lv, J., Perkovic, V., Yang, L., Zhao, N., Jardine, M. J., Cass, A., Zhang, H., & Wang, H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht065 · Cited by 192
Brookhart, M. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.847 · Cited by 192
A PCSK9 Missense Variant Associated with a Reduced Risk of Early-Onset Myocardial Infarction
Kathiresan, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707445 · Cited by 183
Relationship of Lipoproteins to Cardiovascular Events
Guyton, J. R., Slee, A. E., Anderson, T., Fleg, J. L., Goldberg, R. B., Kashyap, M. L., Marcovina, S. M., Nash, S. D., O'Brien, K. D., Weintraub, W. S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.023 · Cited by 182
Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
Preiss, D., Tikkanen, M. J., Welsh, P., Ford, I., Lovato, L. C., Elam, M. B., LaRosa, J. C., DeMicco, D. A., Colhoun, H. M., Goldenberg, I., et al. (2012) · JAMA · doi:10.1001/jama.2012.8439 · Cited by 181
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy
Waters, D. D., Ho, J. E., Boekholdt, S. M., DeMicco, D. A., Kastelein, J. J. P., Messig, M., Breazna, A., & Pedersen, T. R. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.042 · Cited by 178
The Severe Hypercholesterolemia Phenotype
Sniderman, A. D., Tsimikas, S., & Fazio, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.060 · Cited by 177
Nasir, K., Michos, E. D., Blumenthal, R. S., & Raggi, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.052 · Cited by 177
Smoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus
Al-Delaimy, W. K., Manson, J. E., Solomon, C. G., Kawachi, I., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.273 · Cited by 173
Murphy, S. A., Cannon, C. P., Wiviott, S. D., McCabe, C. H., & Braunwald, E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.005 · Cited by 173
Hypertriglyceridemia and acute pancreatitis
Murphy, M. J., Sheng, X., MacDonald, T. M., & Wei, L. (2013) · JAMA Internal Medicine · doi:10.1001/2013.jamainternmed.477 · Cited by 172
Trends in obesity and abdominal obesity among adults in the United States from 1999–2008
Ford, E. S., Li, C., Zhao, G., & Tsai, J. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.186 · Cited by 170
Novel Antipsychotics and Severe Hyperlipidemia
Meyer, J. M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00003 · Cited by 168
An assessment by the Statin Intolerance Panel: 2014 update
Guyton, J. R., Bays, H. E., Grundy, S. M., & Jacobson, T. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.03.002 · Cited by 165
Self-citationEthnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause Mortality
Nasir, K., Shaw, L. J., Liu, S. T., Weinstein, S. R., Mosler, T. R., Flores, P. R., Flores, F. R., Raggi, P., Berman, D. S., Blumenthal, R. S., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.066 · Cited by 164
A clinician's guide to statin drug-drug interactions
Kellick, K. A., Bottorff, M., & Toth, P. P. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.02.010 · Cited by 164
Cardiovascular effects of statins, beyond lipid-lowering properties
Mihos, C. G., Pineda, A. M., & Santana, O. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.009 · Cited by 162
Lackland, D. T., Elkind, M. S. V., D’Agostino, R. B., Dhamoon, M. S., Goff, D. C., Higashida, R. T., McClure, L. A., Mitchell, P. H., Sacco, R. L., Sila, C. A., et al. (2012) · Stroke · doi:10.1161/str.0b013e31825bcdac · Cited by 161
Gower, R. M., Wu, H., Foster, G. A., Devaraj, S., Jialal, I., Ballantyne, C. M., Knowlton, A. A., & Simon, S. I. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.215434 · Cited by 160
Ramjee, V., Sperling, L. S., & Jacobson, T. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.009 · Cited by 157
Self-citationEvaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Bairaktari, E. T., Seferiadis, K. I., & Elisaf, M. (2005) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840501000106 · Cited by 151
Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
Mannucci, E., Dicembrini, I., Lauria, A., & Pozzilli, P. (2013) · Diabetes Care · doi:10.2337/dcs13-2018 · Cited by 150
Cook, N. R., & Ridker, P. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5336 · Cited by 149
Atherosclerosis and Cardiovascular Disease
Tsimikas, S., Tsironis, L. D., Tselepis, R. D., Thromb, A., July, V. B., In, L.-A. P. A., Tsimikas, S., Tsironis, L. D., & Tselepis, R. D. (1990) · Springer eBooks · doi:10.1007/978-94-009-0731-7 · Cited by 149
LaRosa, J. C., Grundy, S. M., Kastelein, J. J. P., Kostis, J. B., & Greten, H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.102 · Cited by 148
Self-citationIto, M. K., McGowan, M. P., & Moriarty, P. M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.001 · Cited by 140
Self-citationRobinson (2012) · doi:10.1016/j.amjcard.2012.07.007 · Cited by 137
Libby, P., Schoenbeck, U., Mach, F., Selwyn, A. P., & Ganz, P. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00041-2 · Cited by 136
HDL-C: Role as a risk modifier
Barter, P. J. (2011) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(11)70885-6 · Cited by 135
Simpson, R. J., & Mendys, P. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.026 · Cited by 132
Dod, H. S., Bhardwaj, R., Sajja, V., Weidner, G., Hobbs, G. R., Konat, G. W., Manivannan, S., Gharib, W., Warden, B. E., Nanda, N. C., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.038 · Cited by 130
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100
Véniant, M. M., Sullivan, M. A., Kim, S. K., Ambroziak, P., Chu, A., Wilson, M. D., Hellerstein, M. K., Rudel, L. L., Walzem, R. L., & Young, S. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10695 · Cited by 130
Mantel-Teeuwisse, A. K., Kloosterman, J. M. E., der Zee, A. H. M., Klungel, O. H., Porsius, A. J., & de Boer, A. (2001) · Drug Safety · doi:10.2165/00002018-200124060-00003 · Cited by 127
Secondary Causes of Dyslipidemia
Vodnala, D., Rubenfire, M., & Brook, R. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.062 · Cited by 123
Cole, T. G., Contois, J. H., Csako, G., McConnell, J. P., Remaley, A. T., Devaraj, S., Hoefner, D. M., Mallory, T., Sethi, A. A., & Warnick, G. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196733 · Cited by 122
An assessment by the Statin Cognitive Safety Task Force: 2014 update
Rojas‐Fernandez, C. H., Goldstein, L. B., Levey, A. I., Taylor, B. A., Bittner, V., & The National Lipid Association's Safety Task Force (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.02.013 · Cited by 120
An assessment by the Statin Diabetes Safety Task Force: 2014 update
Maki, K. C., Ridker, P. M., Brown, W. V., Grundy, S. M., & Sattar, N. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.02.012 · Cited by 119 · cited 2×
“Therefore, the panel recommends that fasting glucose or glycated hemoglobin be checked before initiation of statin therapy and within 1 year afterward in those with diabetes risk factors.(324) In addition, lifestyle therapies should be emphasized, both to aid in lowering levels of atherogenic cholesterol and for reduc…”
BackgroundSelf-citationBlaha, M. J., Silverman, M. G., & Budoff, M. J. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000341 · Cited by 119
C-reactive protein and risk of cardiovascular disease: Evidence and clinical application
Ridker, P. M., Bassuk, S. S., & Toth, P. P. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0004-3 · Cited by 118
Buchwald, H., Varco, R. L., Boen, J. R., Williams, S. E., Hansen, B. J., Campos, C. T., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., et al. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1253 · Cited by 116
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
Benner, J. S., Tierce, J. C., Ballantyne, C. M., Prasad, C., Bullano, M. F., Willey, V. J., Erbey, J., & Sugano, D. S. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422003-00003 · Cited by 115
Ballantyne, C. M., Bertolami, M. C., García, H. R. H., Nul, D. R., Stein, E. A., Théroux, P., Weiss, R., Cain, V. A., & Raichlen, J. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.12.013 · Cited by 112
Ballantyne, C. M., Raichlen, J. S., & Cain, V. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.052 · Cited by 111
Use of vaccines as probes to define disease burden
Feikin, D. R., Scott, J. A. G., & Gessner, B. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61682-7 · Cited by 111
Ahmed, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl220 · Cited by 110
Remnant lipoproteins as therapeutic targets
Havel, R. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00008 · Cited by 107
Holme, I., Aastveit, A. H., Jungner, I., & Walldius, G. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01925.x · Cited by 106
van Wijk, D. F., Sjouke, B., Figueroa, A. L., Emami, H., van der Valk, F. M., MacNabb, M. H., Hemphill, L., Schulte, D. M., Koopman, M. G., Lobatto, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.088 · Cited by 105
Anderson, K. M., Wilson, P. W. F., Garrison, R. J., & Castelli, W. P. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90094-3 · Cited by 105
Ensign, W. Y., Hill, N. S., & Heward, C. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059949 · Cited by 103
The Necessity for Clinical Reasoning in the Era of Evidence-Based Medicine
Sniderman, A. D., Lachapelle, K. J., Rachon, N. A., & Furberg, C. D. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.07.012 · Cited by 99
Barylski, M., Nikfar, S., Mikhailidis, D. P., Toth, P. P., Salari, P., Ray, K. K., Pencina, M. J., Rizzo, M., Rysz, J., Abdollahi, M., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.007 · Cited by 98
Chung, B. H., Tallis, G. A., Yalamoori, V., Anantharamaiah, G. M., & Segrest, J. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.622 · Cited by 97
Calvert, S. B., Kramer, J. M., Anstrom, K. J., Kaltenbach, L. A., Stafford, J. A., & LaPointe, N. M. A. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.01.019 · Cited by 97
NLA Task Force on Statin Safety - 2014 update
Jacobson, T. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.03.003 · Cited by 96
Self-citationChunyu, Z., Christina, K., Katsunori, I., & Sacks, F. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p600011-jlr200 · Cited by 95
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Nicholls, S. J., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., Borgman, M., Wolski, K., et al. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000414260.89578.71 · Cited by 95
Pleiotropic effects of pitavastatin
Davignon, J. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04139.x · Cited by 88
National Lipid Association Annual Summary of Clinical Lipidology 2015
Bays, H. E., Jones, P. H., Brown, W. V., & Jacobson, T. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.10.002 · Cited by 88
Self-citationMaki, K. C., Bays, H. E., & Dicklin, M. R. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.003 · Cited by 83 · cited 3×
“Prospective epidemiologic studies and meta-analyses have demonstrated a positive relationship between serum triglyceride levels and incidence of ASCVD, although the mechanisms responsible for this association are not fully understood.(198) Possible pathophysiological links include (1) the atherogenicity of smaller spe…”
BackgroundInfluentialSelf-citationRyan, M. C., Farin, H. M. F., Abbasi, F., & Reaven, G. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.096 · Cited by 82
ACCF 2012 Health Policy Statement on Patient-Centered Care in Cardiovascular Medicine
Walsh, M. N., Bové, A. A., Cross, R. J., Ferdinand, K. C., Forman, D. E., Freeman, A. M., Hughes, S., Klodas, E., Koplan, M., Lewis, W. R., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.016 · Cited by 82
Gudzune, K. A., Monroe, A. K., Sharma, R., Ranasinghe, P. D., Chelladurai, Y., & Robinson, K. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2526 · Cited by 80
Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression
Kaur, N., Pandey, A., Negi, H., Shafiq, N., Reddy, S., Kaur, H., Chadha, N., & Malhotra, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094585 · Cited by 80
Remnant lipoproteins and atherosclerosis
Twickler, T. B., Dallinga‐Thie, G. M., Chapman, M. J., & Cohn, J. S. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0037-x · Cited by 76
González‐Pacheco, H., Vallejo, M., Altamirano‐Castillo, A., Vargas‐Barrón, J., Piña-Reyna, Y., Sánchez-Tapia, P., & Martínez‐Sánchez, C. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s67945 · Cited by 75
Headed in the Right Direction But at Risk for Miscalculation
Amin, N. P., Martin, S. S., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Michos, E. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.010 · Cited by 70
Elshazly, M. B., Martin, S. S., Blaha, M. J., Joshi, P. H., Toth, P. P., McEvoy, J. W., Al-Hijji, M. A., Kulkarni, K. R., Kwiterovich, P. O., Blumenthal, R. S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.045 · Cited by 68
Predicting waist circumference from body mass index
Bozeman, S. R., Hoaglin, D. C., Burton, T. M., Pashos, C. L., Ben-Joseph, R. H., & Hollenbeak, C. S. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-115 · Cited by 68
Sex- and gender-related risk factor burden in patients with premature acute coronary syndrome
Choi, J., Daskalopoulou, S. S., Thanassoulis, G., Karp, I., Pelletier, R., Behlouli, H., & Pilote, L. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.674 · Cited by 68
Witte, D. R., Taskinen, M., Perttunen-Nio, H., van Tol, A., Livingstone, S. J., & Colhoun, H. M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300395-jlr200 · Cited by 67
Budoff, M. J., Möhlenkamp, S., McClelland, R. L., Delaney, J. A., Bauer, M., Jöckel, H. K., Kälsch, H., Kronmal, R. A., Nasir, K., Lehmann, N., et al. (2013) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2013.05.009 · Cited by 63
Using Apolipoprotein B to Manage Dyslipidemic Patients: Time for a Change?
Harper, C. R., & Jacobson, T. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0517 · Cited by 61
Self-citationMediterranean diet and cardiovascular disease: historical perspective and latest evidence
de Lorgeril, M. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0370-4 · Cited by 60
On- and Off-Target Pharmacology of Torcetrapib
Johns, D. G., Duffy, J., Fisher, T. S., Hubbard, B. K., & Forrest, M. J. (2012) · Drugs · doi:10.2165/11599310-000000000-00000 · Cited by 60
Hu, F. B., & Willett, W. C. (2001) · PubMed · Cited by 59
"The metabolic syndrome... is dead": These reports are an exaggeration
Tenenbaum, A., & Fisman, E. Z. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-11 · Cited by 59
Puri, R., Nissen, S. E., Shao, M., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303932 · Cited by 58
Late-Breaking Clinical Trial Abstracts
Wilkins, L. (2002) · Circulation · doi:10.1161/01.cir.0000457464.79076.2c · Cited by 58
Wang, J., Razuvaev, A., Folkersen, L., Hedin, E., Roy, J., Brismar, K., & Hedin, U. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.032 · Cited by 56
The IDEAL Cholesterol: Lower Is Better
Cannon, C. P. (2005) · JAMA · doi:10.1001/jama.294.19.2492 · Cited by 55
Farwell, W. R., Sesso, H. D., Buring, J. E., & Gaziano, J. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.044 · Cited by 53
Grundy, S. M., Vega, G. L., Tomassini, J. E., & Tershakovec, A. M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.018 · Cited by 51
Self-citationGamboa, C. M., Safford, M. M., Levitan, E. B., Mann, D. M., Yun, H., Glasser, S. P., Woolley, J. M., Robert, R., Farkouh, M., & Muntner, P. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000292 · Cited by 50
Robinson, J. G., Colhoun, H. M., Bays, H. E., Jones, P. H., Du, Y. E., Hanotin, C., & Donahue, S. (2014) · Clinical Cardiology · doi:10.1002/clc.22327 · Cited by 49
Self-citationIto, M. K., Maki, K. C., Brinton, E. A., Cohen, J. D., & Jacobson, T. A. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.006 · Cited by 49
Self-citationВладиславович, Е. М., Safarova, M. S., Afanasieva, O. I., Kukharchuk, V. V., & Pokrovsky, S. N. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.944 · Cited by 47
Yeboah, J., Carr, J. J., Terry, J. G., Ding, J., Zeb, I., Liu, S., Nasir, K., Post, W. S., Blumenthal, R. S., & Budoff, M. J. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313492065 · Cited by 47
Statins and myocardial remodelling: cell and molecular pathways
Porter, K. E., & Turner, N. A. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001931 · Cited by 46
Li, N., Li, Q., Tian, X.-Q., Qian, H.-Y., & Yang, Y.-J. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0077-0 · Cited by 45
Ezetimibe Therapy for Dyslipidemia: An Update
Katsiki, N., Theocharidou, E., Karagiannis, A. I., Athyros, V. G., & Mikhailidis, D. P. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990314 · Cited by 44
Safety and Effect of Very Low Levels of Low-Density Lipoprotein Cholesterol on Cardiovascular Events
LaRosa, J. C., Pedersen, T. R., Somaratne, R. M., & Wasserman, S. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.052 · Cited by 43
Toth, P. P. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.02.004 · Cited by 39
Ma, X., & Zhu, S. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.24 · Cited by 39
Starting Primary Prevention Earlier With Statins
Robinson, J. G. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.076 · Cited by 38
Lim, S. K., Sakuma, I., Quon, M. J., & Koh, K. K. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.037 · Cited by 37
Rallidis, L. S., Pitsavos, C. E., Panagiotakos, D. B., Sinos, L., Stefanadis, C., & Kremastinos, D. T. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.09.022 · Cited by 36
van de Woestijne, A. P., Wassink, A. M. J., Monajemi, H., Liem, A. H., Nathoe, H. M., van der Graaf, Y., & Visseren, F. L. J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.008 · Cited by 36
Pathophysiology and Therapeutics of Cardiovascular Disease in Metabolic Syndrome
Wang, Y., Yu, Q., Chen, Y., & Cao, F. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270002 · Cited by 36
Diagnosis and treatment of severe hypertriglyceridemia
Viljoen, A., & Wierzbicki, A. S. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.21 · Cited by 36
Sasaki, J., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Itakura, H., Hishida, H., Kita, T., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8326 · Cited by 35
Ma, S., & Ma, C. C.-H. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.05.004 · Cited by 35
Grundy, S. M., Vega, G. L., Tomassini, J. E., & Tershakovec, A. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.003 · Cited by 33
Self-citationClassification of LDL Phenotypes by 4 Methods of Determining Lipoprotein Particle Size
Sninsky, J. J., Rowland, C. M., Baca, A. M., Caulfield, M. P., & Superko, H. R. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31829d9d17 · Cited by 30
de Vries, M. A., Klop, B., & Cabezas, M. C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.024 · Cited by 29
Skoumas, I., Masoura, C., Pitsavos, C. E., Tousoulis, D., Papadimitriou, L., Aznaouridis, K. A., Chrysohoou, C. A., Giotsas, N., Toutouza, M. G., Tentolouris, C. A., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.005 · Cited by 29
Agrawal, M., Spencer, H. J., & Faas, F. H. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181fb7ca7 · Cited by 28
Ito, M. K., Delucca, G. M., & Aldridge, M. A. (2001) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840100600204 · Cited by 28
Self-citationStockman, J. A. (2011) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(09)79582-x · Cited by 28
Emerging low-density lipoprotein therapies: Microsomal triglyceride transfer protein inhibitors
Goldberg, A. C. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.03.003 · Cited by 27
Cohen, J. D., Aspry, K. E., Brown, A. S., Foody, J. M., FURMAN, R. E., Jacobson, T. A., Karalis, D. G., Kris‐Etherton, P. M., LaForge, R., O'Toole, M. F., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.002 · Cited by 27
Self-citationBallantyne, C. M., Pitt, B., Loscalzo, J., Cain, V. A., & Raichlen, J. S. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.037 · Cited by 26
Russo, G. T., Giandalia, A., Romeo, E. L., Marotta, M., Alibrandi, A., Francesco, C. D., Horvath, K. V., Asztalos, B. F., & Cucinotta, D. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0023-z · Cited by 26
Skoumas, I., Masoura, C., Aznaouridis, K. A., Metaxa, V., Tsokanis, A., Papadimitriou, L., Tousoulis, D., Pitsavos, C. E., & Stefanadis, C. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0320 · Cited by 26
Mahajan, N., Ference, B. A., Arora, N. P., Madhavan, R., Bhattacharya, P. D., Sudhakar, R., Sagar, A., Wang, Y., Sacks, F. M., & Afonso, L. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.010 · Cited by 24
deGoma, E. M., Dunbar, R. L., Jacoby, D. S., & French, B. C. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.025 · Cited by 24
Toenail Nicotine Levels as Predictors of Coronary Heart Disease among Women
Al‐Delaimy, W. K., Stampfer, M. J., Manson, J. E., & Willett, W. C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn061 · Cited by 24
Are We Moving Towards Concordance on the Principle That Lipid Discordance Matters?
Martin, S. S., & Michos, E. D. (2013) · Circulation · doi:10.1161/circulationaha.113.007207 · Cited by 23
Beyond statins: what to expect from add-on lipid regulating therapy?
Laufs, U., Weintraub, W., & Packard, C. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht213 · Cited by 22
Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
Τζιόμαλος, Κ., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010085 · Cited by 20
Coronary Artery Calcium and Primary Prevention Risk Assessment: What Is the Evidence?
Whelton, S. P., Nasir, K., Blaha, M. J., Gransar, H., Metkus, T. S., Coresh, J., Berman, D. S., & Blumenthal, R. S. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965566 · Cited by 19
Lowering cholesterol in high-risk individuals and populations
Rifkind, B. M. (1995) · M. Dekker eBooks · Cited by 18
‘Trig-onometry’: non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia
Jacobson, T. A. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02547.x · Cited by 18
Self-citationCardiometabolic risk reduction in an intensive cardiovascular health program
Voeghtly, L., Neatrour, D. M., Decewicz, D. J., Burke, A., Haberkorn, M. J., Lechak, F., Patney, H. L., Vernalis, M., & Ellsworth, D. L. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.01.012 · Cited by 18
Drug Treatment of Asymptomatic Hypertriglyceridemia to Prevent Pancreatitis: Where Is the Evidence?
Lederle, F. A., & Bloomfield, H. E. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-9-201211060-00011 · Cited by 16
Understanding the Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Paradox
Green, J. B. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2767 · Cited by 16
Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
Stefanutti, C., Labbadia, G., & Athyros, V. G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140620120130 · Cited by 14
Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence
FELDMAN, E. B. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.6.1594a · Cited by 14
Genetic screening for homozygous and heterozygous familial hypercholesterolemia
Fonseca, F. A. H. (2010) · The Application of Clinical Genetics · doi:10.2147/tacg.s13490 · Cited by 12
Farnier, M., Chen, E., Johnson‐Levonas, A. O., Sisk, C. M., & Mitchel, Y. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s58694 · Cited by 12
Bangalore, S., Fayyad, R. S., Laskey, R. E., DeMicco, D. A., DEEDWANIA, P. C., Kostis, J. B., & Messerli, F. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht315 · Cited by 12
Role of coronary artery calcium in cardiovascular risk assessment
Sunkara, N. T., Wong, N. D., & Malik, S. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.868305 · Cited by 12
Verma, D. R., & Brinton, E. A. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0741 · Cited by 11
Toth, P. P., Thanassoulis, G., Williams, K., Furberg, C. D., & Sniderman, A. D. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.08.004 · Cited by 11
Baruch, L., Chiong, V. J., Agarwal, S., & Gupta, B. P. (2013) · Cholesterol · doi:10.1155/2013/502948 · Cited by 10
Grundy, S. M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.08.032 · Cited by 8
Self-citationHow Low an LDL-C Should We Go With Statin Therapy?
Kostis, W. J. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0388-7 · Cited by 8
Low-Dose Nonlinear Effects of Smoking on Coronary Heart Disease Risk
Cox, L. A. (2011) · Dose-Response · doi:10.2203/dose-response.11-038.cox · Cited by 8
Yamada, K., Tsuji, N., Fujita, T., Tanaka, M., Kuribayashi, K., Kobayashi, D., & Watanabe, N. (2010) · PubMed · Cited by 7
Elimination of Lipid Levels From Quality Measures
Stine, N. W., & Chokshi, D. A. (2014) · JAMA · doi:10.1001/jama.2014.15600 · Cited by 7
Napolitano, M., Botham, K. M., & Bravo, E. (2013) · Cytokine · doi:10.1016/j.cyto.2013.04.025 · Cited by 7
Critical review of non-statin treatments for dyslipoproteinemia
Pang, J., Chan, D. C., & Watts, G. F. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.888312 · Cited by 7
Contemporary Evidence-Based Guidelines
Robinson, J. G. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.008 · Cited by 6
Ference, B. A., Majeed, F., Brook, R. D., Hedquist, L., Penumetcha, R., & Flack, J. M. (2014) · Circulation · Cited by 4
JCL Roundtable: Lipid-lowering drugs in those older than 75 years of age
Brown, W. V., Bittner, V., McKenney, J. M., & Ziajka, P. E. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.09.009 · Cited by 4
Self-citationTreatment Targets in the Management of Dyslipidemias: Which Targets in Whom?
Grundy, S. M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0305-7 · Cited by 4
Self-citation
Cited by
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Self-citationGrundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Self-citationDietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000510 · Cited by 1,386
Grundy, S. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.10.004 · Cited by 882
Self-citationSafety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Ray, K. K., Bays, H. E., Catapano, A. L., Lalwani, N. D., Bloedon, L. T., Sterling, L. R., Robinson, P. L., & Ballantyne, C. M. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803917 · Cited by 807
Self-citation
Metadata
- Authors
- Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., Wilson, D. P., & Brown, W. V.
- Venue
- Journal of Clinical Lipidology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 9
- Issue
- 2
- Pages
- 129-169
- ISSN
- 1876-4789 (ISSN-L)
- 1933-2874
- OpenAlex
- W2121568629
- Cited by
- 773
- References
- 359
- FWCI
- 82.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.